Gärtner, B C, Fischinger, J M, Roemer, K et al. · Journal of virological methods · 2001 · DOI
This study compared three different blood tests for detecting Epstein-Barr virus (EBV) infection: a newer line blot test, a standard ELISA test, and an older reference test called immunofluorescence. The researchers found that all three tests worked well at identifying new infections and past infections, but the line blot and ELISA were less reliable at detecting EBV reactivation (when the virus becomes active again in people with weakened immune systems).
Many ME/CFS patients have abnormal EBV antibody patterns and suspected viral reactivation. Understanding which diagnostic tests accurately detect active EBV reactivation—rather than just prior infection—is essential for identifying whether EBV plays a role in ME/CFS and for appropriate clinical management. This study highlights the need for more reliable reactivation markers.
This study does not establish whether EBV reactivation causes ME/CFS, nor does it prove that antibody testing alone can diagnose EBV reactivation in any patient population. It also does not address whether reactivation correlates with ME/CFS symptoms. The small sample of CFS patients (n=14) limits generalizability to the ME/CFS population.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →